Resources

Dapagliflozin improves glycemic control, stabilizes insulin requirements, and reduces weight without increasing major hypoglycemic episodes when added to insulin therapy in patients with inadequately controlled type 2 diabetes mellitus….

Researchers at Brigham and Women’s Hospital found that men with type 2 diabetes treated with insulin without a history of CVD were at higher risk for major cardiovascular events compared with men who had a history of CVD….

Long-term treatment with metformin is safe for preventing or delaying the development of type 2 diabetes….

Fasting blood glucose may be a biomarker of depression in elderly patients….

Insulin resistance, overweight/obesity, and fatty liver commonly occur together but are independently associated with an increased risk of developing type 2 diabetes….

Talking with diabetic peers who’ve gotten their blood sugar under control helped other African-American diabetes patients bring down their own levels a full point, more than those who were offered $100 to reduce their A1c 1 point or even $200 to reduce their A1c 2 points….

Researchers have discovered that deficiency of a single protein, Mitofusin 2, in muscle and hepatic cells of mice is sufficient to cause tissues to become insensitive to insulin, thus producing an increase in blood glucose concentrations and becoming a potential protein for the treatment of type 2 diabetes….

Tight glycemic control doesn’t help hyperglycemic premature babies and instead impairs some aspects of growth….

  The FDA has approved a key testing phase for an artificial pancreas developed by researchers of the University of Virginia, which could potentially automate care for millions of those with type 1 diabetes….

Circadian rhythms greatly control the production of such key building blocks as amino acids, carbohydrates and lipids, researchers discovered when they analyzed the hundreds of metabolic products present in the liver….